906 followers
New article: Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy https://t.co/syG0GQPEAY #colorectalcancer #oncology https://t.co/P